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Background: Many epidemiological studies have conducted to evaluate the association between serum vitamin D
levels and the risk of kidney stone. The aim of this study was to summarize the evidence from epidemiological
studies between them.
Methods: Pertinent studies were identified by a search of PubMed, Embase, the Cochrane Library, China National
Knowledge Infrastructure (CNKI) and China Biology Medical literature up to July 2015. Standardized mean difference
(SMD) was conducted to combine the results. Random-effect model was used. Publication bias was estimated using
Egger’s regression asymmetry test.
Results: Seven articles involving 451 kidney stone cases and 482 controls were included in this meta-analysis. Our
pooled results suggested that kidney stone patients had a significantly higher serum vitamin D level compared with
controls [summary SMD = 0.65, 95 % CI = 0.51, 0.79, I2 = 97.0 %]. The associations were also significant both in Europe
[SMD = 0.35, 95 % CI = 0.17, 0.53] and in Asia [SMD = 1.00, 95 % CI = 0.76, 1.25]. No publication bias was found.
Conclusions: Our analysis indicated that serum vitamin D level in kidney stone patients was significantly higher than
that in non-kidney stone controls, both in Europe and Asia populations.
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Kidney stone disease is common in the general population
with an estimated prevalence of about 3–5 % in fema-
lesand 10–15 % in males [1]. The most common type
(about >80 %) is the calcium-based kidney stone, and
high urine calcium excretion is a strong risk factor
for stone formation [2, 3]. Prior studies had shown
that a higher concentration of the active vitamin D
metabolite, 1,25-dihydroxyvitamin D, is associated
with increased urinary calcium excretion [4, 5], which
could lead to increase the risk of stone formation.
Despite vitamin D played an important role of in
maintaining bone health, as well as a variety of other
physiologic functions [6], many clinicians are reluctant
to treat vitamin D deficiency or insufficiency in kidney
stone formers because of the theoretical risk of* Correspondence: wanghai150701@163.com
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likely derives from the fact that vitamin D is often cited
as a risk factor for kidney stones [7]. To date, a number
of epidemiologic studies have been published exploring
the relationship between serum vitamin D level and
kidney stone risk. The aim of this meta-analysis was to
(1) assess the association of serum vitamin D levels in
kidney stone patients compared with the non-kidney
stone controls; and (2) assess heterogeneity and publica-
tion bias among the studies we analyzed.Methods
Literature search
Two authors independently searched the databases of
PubMed, Embase, the Cochrane Library, China National
Knowledge Infrastructure (CNKI) and China Biology
Medical literature for relevant articles published before
July 2015 using the following search terms: ‘cholecalciferol’
OR ‘ergocalciferol’ OR ‘vitamin*’ AND ‘kidney stone’ ORis distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
Fig. 1 The flow diagram of screened, excluded, and analyzed
publications
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or Chinese. In addition, we reviewed references of
obtained articles. Disagreements between the two authors
were resolved by consensus with a third author.
Study selection
Studies were eligible for analysis if they met the
following criteria: (1) the studies were in case–control
or cohort design or cross-sectional design or random-
ized controlled trials; (2) the exposure was serum
vitamin D level; (3) the end point was kidney stone;
(4) available mean and standard deviation (SD) of
serum vitamin D level or data provided from which
mean and SD could be calculated; and (5) unrelated
case and control groups or exposed and unexposed
groups in cohort study and all subjects from the same
temporally and geographically defined underlying
population. Accordingly, the following exclusion
criteria were also used: (1) reviews and (2) repeated
or overlapped publications.
Data extraction
We extracted data from the included articles, with
particular regards to: the last name of the first author,
publication year, country of region, study design, study
population, age for cases and controls, number of cases
and controls, the mean ± SD of serum vitamin D levels,
and statistical adjustment for the main confounding or
mediating factors.
Statistical analysis
Pooled measure was performed on the standardized
mean difference (SMD) with 95 % CI to assess the
strength of association between serum vitamin D level
and risk of kidney stone. Random-effects model was
used to combine study-specific SMD (95 % CI), which
considers both within-study and between-study variation
[8]. The Q test and I2 of Higgins and Thompson [9]
were used to assess heterogeneity among included
studies. I2 describes the proportion of total variation
attributable to between-study heterogeneity as opposed
to random error or chance, with suggested thresholds
for low (25–50 %), moderate (50–75 %) and high
(>75 %) heterogeneity, respectively [10]. Meta-regression
and subgroup analyses were performed to assess the
potentially important covariates that might exert sub-
stantial impact on between-study heterogeneity [11].
We used the Egger regression asymmetry test to
evaluate the publication bias [12]. Sensitivity analysis
was conducted to describe how robust the pooled
estimator was to removal of individual studies [13].
An individual study is suspected of excessive influ-
ence, if the point estimate of its omitted analysis lies
outside the 95 % CI of the combined analysis. Allstatistical analyses were performed using Stata 12.0
(Stata Corp, College Station, Texas, USA). Two-tailed
P ≤ 0.05 was accepted as statistically significant.
Results
Literature search
A total of 3558 citations were retrieved from the
electronic databases. After initial screening of titles
and abstracts using the aforementioned criteria, 45
articles were identified for full-text review (all the 45
articles were cited as a Additional file 1). Of these, 38
were further excluded, leaving seven eligible articles
(Fig. 1). Hence, seven articles [14–20] involving 451
kidney stone cases and 482 controls were included in
our final meta-analysis. Two studies were come from
Iran, one from United States, one from Netherlands,
one from Germany, one from Italy and one from
Sweden. The characteristics of these included studies
are presented in Table 1.
Serum vitamin D level and kidney stone risk
Five of these included studies reported an increased
risk of kidney stone for serum vitamin D levels in
kidney stone patients compared with controls, while
no significant association was reported in two stud-
ies. Our pooled results suggested that kidney stone
patients had a significantly higher serum vitamin D
level compared with non-kidney stone controls [sum-
mary SMD = 0.65, 95 % CI = 0.51, 0.79], with high
between-study heterogeneity detected (I2 = 97.0 %,
Pheterogeneity = 0.000) (Fig. 2).




















Sweden Symptomatic Case-control 38 (34) Na 26.2 ± 1.6 32 (16) Na 17.6 ± 0.9
Fallahzadeh
et al. [15]
Iran Ultrasounds Case-control 36 (24) 8.4 ± 4.7
months





Italy Symptomatic Case-control 25 (16) 41.2 ± 2.4 39.6 ± 2.6 15 (7) 49.0 ± 3.7 28.9 ± 1.8
Jarrar et al. [17] Germany Ultrasounds Case-control 57 (35) 54.92 ± 23.32 53.65 ± 27.46 44 (22) 53.34 ± 18.51 48.3 ± 30.8




29 (22) 48 ± 12 35 ± 10 29 (22) 48 ± 12 17 ± 6
Netelenbos
et al. [19]
Netherlands Symptomatic Case-control 160 (106) 43 ± 14 55 ± 23 217 (147) 39 ± 11 53 ± 22
Shakhssalim
et al. [20]
Iran Symptomatic Case-control 106 (106) 43.4 ± 6.9 127 ± 40 109 (109) 38.4 ± 6.9 93 ± 35
SD standard deviation; Na not available
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As seen in Fig. 2, evidence of high between-study
heterogeneity (I2 = 97.0 %, Pheterogeneity = 0.000) was
found in the pooled results. In order to explore the high
between-study heterogeneity founded in the analysis,
univariate meta-regression with the covariates of publi-
cation year, study design and geographic locations were
performed. However, no significant findings were found
in the above-mentioned analysis.
For the subgroup analyses by study design, the
association was also significant in case–control studiesFig. 2 The forest plot of the association between serum vitamin D levels a[SMD = 0.57, 95 % CI = 0.43, 0.72; I2 = 97.2 %] of
serum vitamin D levels in kidney stone patients
compared with the controls. There is only one study
was randomized controlled trials design, and no
pooled results for other study design was combined.
In subgroup analyses of geographic locations, when
we restricted the analysis to Europe and Asia, the
associations were significant both in European popu-
lations [SMD = 0.35, 95 % CI = 0.17, 0.53; I2 = 98.1 %]
and in Asian populations [SMD = 1.00, 95 % CI = 0.76,
1.25; I2 = 51.4 %].nd kidney stone risk
Wang et al. Nutrition Journal  (2016) 15:32 Page 4 of 5Sensitivity analysis and publication bias
Sensitivity analysis showed that no individual study
had excessive influence on the association of serum
vitamin D levels with the risk of kidney stone. Egger’s
regression asymmetry test (P = 0.596) showed no
evidence of significant publication bias between serum
vitamin D levels and kidney stone risk.
Discussion
In this study, data were available with 451 kidney stone
cases and 482 controls for the analysis. This work
provided convincing evidence that serum vitamin D level
in kidney stone patients was significantly higher than
that in non-kidney stone controls. The associations were
also significant both in Europe and in Asia populations.
In our study, significant between-study heterogeneity
was found between serum vitamin D levels and kidney
stone risk. Previous paper [21] had reported that hetero-
geneity is common in the meta-analyses. To explore the
potential sources of between-study heterogeneity is
therefore an essential component of meta-analysis. The
high degree of heterogeneity might have arisen from
publication year, study design and geographic locations.
Therefore, we used meta-regression to explore the
causes of heterogeneity by covariates. However, no
covariate had significant impact on the high between-
study heterogeneity among those mentioned above.
Considering the pooled meta-analysis was fraught
with the problem of heterogeneity, subgroup analyses
by study design and geographic locations to explore
the source of heterogeneity. However, between-study
heterogeneity persisted in some of the subgroups,
suggesting the presence of other unknown confound-
ing factors. Other environment variables, as well as
their possible interaction, may well be potential
contributors to the heterogeneity observed.
As a meta-analysis of published studies, our findings
showed some advantages. First, a highlight of this study
was that we found a significant association between
serum vitamin D levels and the risk of kidney stone.
Second, the current study included more kidney stone
cases and controls; this may derive a more precise
estimation of the relationship between serum vitamin D
and kidney stone risk. Third, no significant publication
bias was detected in this meta-analysis.
There are some limitations in this meta-analysis
should be concerned. First, six of the seven studies were
case–control design and only one study was randomized
controlled trials design. Although case–control studies
may suffer from recall bias and selection bias, case–con-
trol studies are important methods in etiology research.
More studies with other study design are wanted in the
future studies. Second, as a meta-analysis of epidemio-
logic studies, we cannot rule out that individual studiesmay have failed to control for potential confounders,
which may introduce bias in an unpredictable direction.
Third, for the subgroups of geographic locations, the as-
sociations were significant both in Europe and in Asia
between serum vitamin D levels and kidney stone risk.
Only one study was conducted from United States.
Thus, we did not combine the results for other popula-
tions. Due to this limitation, the results are applicable to
Europe and Asia, but cannot be extended to other popu-
lations. More studies originating in other countries are
required to investigate the association between serum
vitamin D levels and kidney stone risk. Finally, between-
study heterogeneity was high in the pooled analysis, but
the heterogeneity was not successfully explained by the
subgroup analysis and meta-regression. However, other
environment variables, as well as their possible inter-
action may be potential contributors to this disease-
effect unconformity.
Conclusions
Findings from this meta-analysis suggest that serum
vitamin D level in kidney stone patients was significantly
higher than that in controls.
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